Index of artpub/2022/290606/

Wu, Yi-Long
Postoperative Chemotherapy Use and Outcomes From ADAURA : Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
2022
https://ddd.uab.cat/record/290606